Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$42.43 - $70.83 $228,443 - $381,348
5,384 New
5,384 $366,000
Q1 2024

Apr 10, 2024

BUY
$56.27 - $73.77 $48,223 - $63,220
857 Added 14.95%
6,588 $454,000
Q4 2023

Jan 04, 2024

BUY
$59.06 - $75.72 $23,387 - $29,985
396 Added 7.42%
5,731 $423,000
Q3 2023

Oct 04, 2023

BUY
$65.94 - $99.04 $11,605 - $17,431
176 Added 3.41%
5,335 $363,000
Q2 2023

Jul 06, 2023

BUY
$62.68 - $95.05 $20,559 - $31,176
328 Added 6.79%
5,159 $484,000
Q1 2023

Apr 06, 2023

BUY
$47.19 - $70.77 $35,628 - $53,431
755 Added 18.52%
4,831 $327,000
Q4 2022

Jan 05, 2023

BUY
$30.35 - $53.15 $123,706 - $216,639
4,076 New
4,076 $202,000
Q2 2022

Jul 07, 2022

SELL
$35.61 - $76.23 $109,821 - $235,093
-3,084 Closed
0 $0
Q1 2022

Apr 05, 2022

SELL
$57.56 - $82.54 $2,820 - $4,044
-49 Reduced 1.56%
3,084 $216,000
Q4 2021

Jan 05, 2022

SELL
$72.5 - $100.68 $61,552 - $85,477
-849 Reduced 21.32%
3,133 $244,000
Q3 2021

Oct 05, 2021

BUY
$90.24 - $124.05 $13,987 - $19,227
155 Added 4.05%
3,982 $380,000
Q2 2021

Jul 06, 2021

BUY
$93.66 - $139.27 $6,087 - $9,052
65 Added 1.73%
3,827 $476,000
Q1 2021

Apr 05, 2021

BUY
$116.57 - $155.01 $11,307 - $15,035
97 Added 2.65%
3,762 $496,000
Q4 2020

Jan 07, 2021

BUY
$99.61 - $142.12 $2,490 - $3,553
25 Added 0.69%
3,665 $485,000
Q3 2020

Oct 06, 2020

BUY
$72.92 - $102.01 $21,073 - $29,480
289 Added 8.62%
3,640 $371,000
Q2 2020

Jul 06, 2020

BUY
$55.75 - $92.75 $186,818 - $310,805
3,351 New
3,351 $291,000
Q1 2020

Apr 03, 2020

SELL
$37.9 - $104.44 $106,574 - $293,685
-2,812 Closed
0 $0
Q4 2019

Jan 24, 2020

BUY
$77.66 - $99.74 $14,056 - $18,052
181 Added 6.88%
2,812 $260,000
Q1 2019

Apr 03, 2019

BUY
$61.98 - $96.5 $163,069 - $253,891
2,631 New
2,631 $228,000
Q4 2018

Jan 03, 2019

SELL
$56.04 - $82.66 $147,441 - $217,478
-2,631 Closed
0 $0
Q3 2018

Oct 03, 2018

BUY
$48.29 - $80.6 $127,050 - $212,058
2,631 New
2,631 $208,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.92B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Fulton Bank, N.A. Portfolio

Follow Fulton Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Fulton Bank, N.A. with notifications on news.